Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Besser, Daniel Dr. (1) Beule, Dieter Dr. (1) Birchmeier, Walter Prof. Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blankenstein, Thomas Prof. Dr. (4) Blüthgen, Nils (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Dittmar, Gunnar Dr. (2) Gossen, Manfred Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Leisegang, Matthias Dr. (1) Leutz, Achim Prof. Dr. (1) Mathas, Stephan Dr. (9) Rehm, Armin Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (12) Uckert, Wolfgang Prof. Dr. (9) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (9) (-) Lusatis, Simone (1) 2003 (3) 2004 (2) (-) 2005 (2) (-) 2006 (5) 2007 (2) 2008 (4) (-) 2009 (3) 2010 (3) 2011 (4) 2012 (2) 2013 (2) 2014 (4) 2015 (3) 2016 (2) 2017 (5) 2018 (2) 2020 (4) 2021 (1) (-) Biology of Malignant Lymphomas (9) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Cell Biology and Gene Therapy (2) Signal Transduction in Tumor Cells (1) 10 Results: Active Filter: Janz, Martin Dr.Lusatis, SimoneBiology of Malignant LymphomasMolecular Cell Biology and Gene Therapy200520062009 Sort: Result score Newest to oldest Oldest to newest October 29, 2009 in Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch September 01, 2009 in Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz April 07, 2009 in Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken May 15, 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas April 01, 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel March 15, 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou February 05, 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller February 01, 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken August 25, 2005 in Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken January 01, 2005 in Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
October 29, 2009 in Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch
September 01, 2009 in Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz
April 07, 2009 in Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken
May 15, 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
April 01, 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
March 15, 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
February 05, 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller
February 01, 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
August 25, 2005 in Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
January 01, 2005 in Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
